fbpx Skip to main content

Member's Profile

Avexegen Therapeutics, Inc.

10210 Campus Point Dr Ste 150
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2016
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Avexegen Therapeutics, Inc.
Biotech Company
Avexegen Therapeutics is an early stage development company working on novel and revolutionary therapies for the $10 Billion GI Market. Our lead drug candidate, Neuregulin-4 (NRG-4), offers a completely new approach to directly heal damaged and inflamed gut tissue in patients with Crohn’s Disease and ulcerative colitis, as well as in premature infants with necrotizing enterocolitis (NEC).
Related News
No related news posted by this Member